Author

Patrick Reid

Peptidream (Japan)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:proteomics· 2 Approach:deep learning· 1 Approach:experimental assay· 1 Organism:mouse· 1 Organism:rat· 1

Frequent Co-Authors

Haruhiko Ogawa· 2 shared Aileen Soriano· 1 shared Anthony W. PartridgeiD· 1 shared Brian M. LaceyiD· 1 shared David Jonathan BennettiD· 1 shared Gireedhar VenkatachalamiD· 1 shared Haruaki KurasakiiD· 1 shared Hidetomo Kitamura· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Haruhiko Ogawa

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Mirror-image mRNA display uncovers isoform-selective D-peptide macrocycles targeting a cryptic KRAS pocket

Matthew J. Mitcheltree, Nicole Boo, Nicolas C. Boyer, Zachary Z. Brown, Xiaomei Chai, Ruchia Duggal, Michael Garrigou, Robert P. Hayes, Jennifer M. Johnston, Hubert B. Josien, Brian M. Lacey, Shuhui Lim, Songnian Lin, Mayhood Todd, Haruhiko Ogawa, , Kaustav Biswas

This paper uses mirror-image mRNA display to discover D-peptide macrocycles targeting a new KRAS binding site, showing selectivity and efficacy in inhibiting KRAS-mutant cells.

bioRxiv · May 22, 2026 · PreprintCancer Biology

A macrocyclic peptide-based fusion inhibitor targeting SARS-CoV-2 Spike S2 subunit

Hirofumi Ohashi, Tatsuro Kawamura, Masaki Ohuchi, Haruaki Kurasaki, Naoko Iwata‐Yoshikawa, Yuichiro Hirata, Saya Moriyama, Kaho Shionoya, Kazutaka Nagatomo, Takayuki Nagasawa, Junpei Yamamoto, Kei Sudo, Naoko Nakamura, Katsuma Matsui, Haruhiko Ogawa, , Koichi Watashi

This paper identifies PA-001, a macrocyclic peptide that inhibits SARS-CoV-2 infection by targeting the S2 subunit's FPPR region, showing broad antiviral activity and efficacy in animal models and clinical trials.

bioRxiv · Mar 6, 2026 · PreprintMicrobiology